ACR Open Rheumatology, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 5, 2024

Objective There are numerous reports of people substituting medical cannabis (MC) for medications. Our obejctive was to investigate the degree which this substitution occurs among with rheumatic conditions. Methods In a secondary analysis from cross‐sectional survey conducted patient advocacy groups in US and Canada, we investigated MC use medication We subgrouped by whether participants substituted medications differences perceived symptom changes patterns, including methods ingestion, cannabinoid content (cannabidiol vs delta‐9‐tetrahydrocannabinol [THC]), frequency. Results Among 763 participants, 62.5% reported products medications, nonsteroidal anti‐inflammatory drugs (54.7%), opioids (48.6%), sleep aids (29.6%), muscle relaxants (25.2%). Following substitution, most decreases or cessation use. The primary reasons were fewer adverse effects, better management, concerns about withdrawal symptoms. Substitution associated THC significantly higher improvements (including pain, sleep, anxiety, joint stiffness) than nonsubstitution, proportion substitutors used inhalation routes those who did not. Conclusion Although determination causality is limited our design, these findings suggest that an appreciable number diseases substitute management. Inhalation containing some commonly identified substituting, disease characteristics not differ status. Further study needed understand role management

Language: Английский